The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Open accessAbstract
In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related and overall mortality. However, only a small proportion of persons with OUD receive these medications. Data from the 2022 National Survey on Drug Use and Health were applied to a cascade of care framework to estimate and characterize U.S. adult populations who need OUD treatment, receive any OUD treatment, and receive medications for OUD. In 2022, 3.7% of U.S. adults aged ≥18 years needed OUD treatment. Among these, only 25.1% received medications for OUD. Most adults who needed OUD treatment either did not perceive that they needed it (42.7%) or received OUD treatment without medications for OUD (30.0%). Compared with non-Hispanic Black or African American and Hispanic or Latino adults, higher percentages of non-Hispanic White adults received any OUD treatment. Higher percentages of men and adults aged 35-49 years received medications for OUD than did women and younger or older adults. Expanded communication about the effectiveness of medications for OUD is needed. Increased efforts to engage persons with OUD in treatment that includes medications are essential. Clinicians and other treatment providers should offer or arrange evidence-based treatment, including medications, for patients with OUD. Pharmacists and payors can work to make these medications available without delays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886 · cited 2×
“††† Several factors limit access to medications for OUD despite strong recommendations for their use ( 4 , 5 ).”
BackgroundMethodSelf-citationSordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
(2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000633 · Cited by 412
Kariisa, M., Davis, N. L., Kumar, S., Seth, P., Mattson, C. L., Chowdhury, F., & Jones, C. M. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7129e2 · Cited by 256
Self-citationRacial Inequality in Receipt of Medications for Opioid Use Disorder
Barnett, M. L., Meara, E., Lewinson, T., Hardy, B., Chyn, D., Onsando, M., Huskamp, H. A., Mehrotra, A., & Morden, N. E. (2023) · New England Journal of Medicine · doi:10.1056/nejmsa2212412 · Cited by 182
Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review
Madden, E. F., Prevedel, S., Light, T., & Sulzer, S. H. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1975749 · Cited by 175
Socias, M. E., Volkow, N. D., & Wood, E. (2016) · Addiction · doi:10.1111/add.13479 · Cited by 92
Self-citationCasillas, S. M., Pickens, C. M. G., Tanz, L. J., & Vivolo-Kantor, A. M. (2024) · Injury Prevention · doi:10.1136/ip-2023-045091 · Cited by 50
Foti, K. E., Heyward, J., Tajanlangit, M., Meek, K., Jones, C. M., Kolodny, A., & Alexander, G. C. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108811 · Cited by 45
Self-citationThematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements
Tiako, M. J. N., Dolan, A. R., Abrams, M. P., Oyekanmi, K. O., Meisel, Z. F., & Aronowitz, S. V. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.18487 · Cited by 28
Cited by
Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder
Wang, W., Volkow, N. D., Wang, Q., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.35247 · Cited by 63
Self-citationWatema-Lord, R., Xie, F., & Sanyal, C. (2025) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2024.102299 · Cited by 5
Metadata
- Authors
- Dowell, D., Brown, S., Gyawali, S., Hoenig, J., Ko, J., Mikosz, C., Ussery, E., Baldwin, G., Jones, C. M., Olsen, Y., Tomoyasu, N., Han, B., Compton, W. M., & Volkow, N. D.
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2024-06-27
- Volume
- 73
- Issue
- 25
- Pages
- 567-574
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W4400083681
- Cited by
- 261
- References
- 10
- FWCI
- 98.79
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment for Opioid Use Disorder: Population Estimates — United States, 2022. https://app.cochat.ai/papers/10.15585/mmwr.mm7325a1
- The paper
- Dowell, D., Brown, S., Gyawali, S., Hoenig, J., Ko, J., Mikosz, C., Ussery, E., Baldwin, G., Jones, C. M., Olsen, Y., Tomoyasu, N., Han, B., Compton, W. M., & Volkow, N. D. (2024). Treatment for Opioid Use Disorder: Population Estimates — United States, 2022. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7325a1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.